In September 2025, the Food and Drug Administration issued over 50 Warning Letters to companies for marketing compounded GLPs as generic versions or that make comparative claims to FDA-approved versions
2018;8:e020445 Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ
For many years we have suspected that one of the ways clinicians can optimize modern psoriasis therapy is through weight management
When looking at the whole patient and potential comorbidities, treatment with GLP-1s may be strongly beneficial for the overall health of many people with substance use challenges, both because of direct benefits as well as the potential to reduce the number of medications that patients require
The Bottom Line Heartburn on a GLP-1 isn't inevitable, but it is common and manageable
PlexusDx tirzepatide therapy, at $289/mo month-to-month, or from $249/mo on the 6-month plan for compounded injection, is priced flatmeaning your dose can increase while your monthly cost remains stable